The Epigenetics Market is predicted to reach USD 1009.248 million with a CAGR of 13.7 % according to Market Data Forecast report.

The Epigenetics Market is predicted to reach USD 1009.248 million with a CAGR of 13.7 % according to Market Data Forecast report.

ID: 1975 | May 2017 | Region: Global


The Epigenetics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report, Global Epigenetics Market was worth USD 533.46 million in 2016 and is expected to reach USD 1009.248 million by 2021 with a CAGR of 13.7 %. Market is segmented by Product (Enzymes (DNA-Modifying Enzymes, Protein-Modifying Enzymes, RNA-Modifying Enzymes), Instruments & Consumables (Mass Spectrometers, Next-Generation Sequencers, QPCR, Sonicators, and others), KITS(Bisulfite Conversion KITS, Chip-Sequence KITS, RNA Sequencing KITS, Whole-Genome Amplification KITS, 5-HMC and 5-MC Analysis KITS, others), Reagents(Antibodies, buffers, Histones, Magnetic Beads, Primers and others)), by Research Area (Developmental Biology, Oncology, Drug Delivery) and by Region – Global Industry Analysis, Share, Size, Growth, Trends, and Forecasts (2016-2021). Geographically, market is further segmented into Asia-Pacific, Europe, North America, Latin America and Middle East and Africa.

Some of the factors like rising prevalence of cancer, increasing funding in R&D, and increasing frequency of research activities are driving the growth of the market. However, lack of trained professionals and high cost of instruments are some of the factors restraining the market.

Oncology segment holds the highest share in the market but drug discovery segment is expected to grow at highest CAGR during forecast period.

North America dominated the global market in 2016 owing to its advanced technology and presence of major players. Asia-Pacific Market is expected to grow at highest CAGR during the forecast period owing to the developing countries like India and China, and increasing R&D spending by companies.

Major players in the global epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation.  

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-epigenetics-market-1969/” and checkout our recent reports in the Biotechnology category at “http://www.marketdataforecast.com/research-reports/healthcare/biotechnology-3/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.